The Victorian government will argue for summary dismissal of two class actions filed over the bungled COVID-19 hotel quarantine program said to be responsible for the state’s second pandemic wave last year.
The High Court has set a date for handing down its keenly anticipated judgment in a case that challenged the winner of a beauty contest of class actions against AMP, a decision expected to offer guidance on how courts should tackle the so-called multiplicity problem.
A group representing insurers has filed another test case over pandemic coverage in business interruption policies, following a landmark loss in a test case concerning an infectious disease exclusion that could cost insurers $10 billion.
Ticket reseller Viagogo is seeking a stay of a $7 million penalty in litigation brought by the ACCC in light of the “catastrophic effect” of the COVID-19 pandemic, as the company appeals a court’s finding that it misled customers on an “industrial scale”.
COVID-19 vaccinations will begin this week, but most employers won’t be able to force staff to get the jab.
Former High Court Justice Kenneth Hayne has called out the ācontinuing and pervasiveā issue of sexual harassment in the legal profession, urging senior lawyers to stop abusing their power.Ā
The High Court will consider whether judges should steer clear of barristers outside the court room, after a husband appealed a ruling by a judge who socialised with his wife’s lawyer during their two-year divorce trial.
The High Court has granted special leave to a British citizen who is locked in a dispute with the Australian Taxation Office over a 15 per cent ābackpacker taxā imposed on holders of Australian working holiday visas.
Two shareholders of failed Arrium Group have secured leave from the High Court to challenge a ruling that nixed their planned examination of a former director to bolster a class action over the collapse of the steel producer.
The High Court will decide whether the Full Court was wrong to overturn a $26.3 million judgment for Danish drug maker H Lundbeck in its long-running patent battle with generic drug maker Sandoz over the patent for blockbuster antidepressant Lexapro.